AWA
RMTI icon

Arkadios Wealth Advisors’s Rockwell Medical RMTI Stock Holding History

Arkadios Wealth Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2
Closed -$492 – 1279
2019
Q4 		$492 Buy
+2
New +$503 ﹤0.01% 929

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SW
SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Arkadios Wealth Advisors's RMTI Position: Q1 2020 in Review

Arkadios Wealth Advisors sold out of Rockwell Medical (RMTI) in Q1 2020, closing a stake of 2 shares — an estimated $492 sold.

Arkadios Wealth Advisors first reported a position in RMTI in Q4 2019 and held it in 1 quarter. The position peaked at $492 in Q4 2019. 79 funds tracked by Wall St. Rank hold RMTI as of Q1 2020.

  • Arkadios Wealth Advisors reported no remaining Rockwell Medical position as of Q1 2020 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 2 Rockwell Medical shares in Q1 2020, an estimated $492.
  • Arkadios Wealth Advisors first reported a position in Rockwell Medical in Q4 2019 and held it in 1 quarter.
  • Arkadios Wealth Advisors's Rockwell Medical position peaked at $492 in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2020.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2020, filed 14 May 2020.